GSE147876 GSE147877 enzalutamide MR42D 4 v 9 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE147876_GSE147877_enzalutamide_MR42D_4_v_9_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE147876_GSE147877_enzalutamide_MR42D_4_v_9_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE147876_GSE147877_enzalutamide_MR42D_4_v_9_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE147876_GSE147877_enzalutamide_MR42D_4_v_9_human_up.

Results found

Linked to

 

Label

Description

 

Gene

H3.3 histone A

Gene

ribosomal protein SA 2

Gene

ribosomal protein S2 pseudogene 5

Gene

deleted in lymphocytic leukemia 2

Gene

long intergenic non-protein coding RNA 632

Gene

LSP1 pseudogene 4

Gene

RNF32 divergent transcript

Gene

DPY19L2 pseudogene 1

Gene

FGF14 antisense RNA 2

Gene

uncharacterized LOC100129434


  • Gene

    ribosomal protein SA 2


  • Gene

    ribosomal protein S2 pseudogene 5


  • Gene

    deleted in lymphocytic leukemia 2


  • Gene

    long intergenic non-protein coding RNA 632


  • Gene

    LSP1 pseudogene 4


  • Gene

    RNF32 divergent transcript


  • Gene

    DPY19L2 pseudogene 1


  • Gene

    FGF14 antisense RNA 2


  • Gene

    uncharacterized LOC100129434

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.